Pancreatic Cancer Research Makes Breakthrough
Posted on 4th August 2015 by Ross Whyte in News
We congratulate the team responsible for the incredible and much-needed breakthrough in pancreatic cancer testing announced in the media this week that will allow the disease to be diagnosed much earlier, potentially giving patients far greater treatment options. Currently, over 80% of people with the disease are diagnosed after it has already spread to other parts of the body, leaving them with little or no prospects for a cure.
The statistics surrounding pancreatic cancer show the devastating impact the disease has on those affected. Brain tumour patients face similarly low survival rates. More children and adults under the age of 40 die of a brain tumour than from any other cancer, and the average five-year survival rate stands at just under 20%. Yet, the science needed to find a cure for this devastating disease receives just 1% of the national spend on cancer research.
With some 16,000 people each year being diagnosed with a brain tumour – and the numbers of those diagnosed with and dying from a brain tumour on the rise – coupled with the fact that up to 40% of all cancers eventually spread to the brain, it is vital that more research is undertaken to bring hope to the thousands of families affected. This disease is responsible for over 20 years of life lost in the average patient, making it the most lethal cancer by this measure.
This chronic underfunding for brain tumour research means that at this rate it could take another 100 years to find a cure. This doesn’t need to be the reality. You can make a difference in so many ways. Whether you take part in one of our fundraising campaigns or sign-up to your own challenge, join us at a lobbying event, sponsor a day of research, leave a gift in your will or simply ‘like’ and follow our social media pages. Together, we will find a cure.